Detection of cell-free microbial DNA using a contaminant-controlled analysis framework
- Author(s)
- Zozaya-Valdés, E; Wong, SQ; Raleigh, J; Hatzimihalis, A; Ftouni, S; Papenfuss, AT; Sandhu, S; Dawson, MA; Dawson, SJ;
- Details
- Publication Year 2021-06-23,Volume 22,Issue #1,Page 187
- Journal Title
- Genome Biology
- Abstract
- BACKGROUND: The human microbiome plays an important role in cancer. Accumulating evidence indicates that commensal microbiome-derived DNA may be represented in minute quantities in the cell-free DNA of human blood and could possibly be harnessed as a new cancer biomarker. However, there has been limited use of rigorous experimental controls to account for contamination, which invariably affects low-biomass microbiome studies. RESULTS: We apply a combination of 16S-rRNA-gene sequencing and droplet digital PCR to determine if the specific detection of cell-free microbial DNA (cfmDNA) is possible in metastatic melanoma patients. Compared to matched stool and saliva samples, the absolute concentration of cfmDNA is low but significantly above the levels detected from negative controls. The microbial community of plasma is strongly influenced by laboratory and reagent contaminants introduced during the DNA extraction and sequencing processes. Through the application of an in silico decontamination strategy including the filtering of amplicon sequence variants (ASVs) with batch dependent abundances and those with a higher prevalence in negative controls, we identify known gut commensal bacteria, such as Faecalibacterium, Bacteroides and Ruminococcus, and also other uncharacterised ASVs. We analyse additional plasma samples, highlighting the potential of this framework to identify differences in cfmDNA between healthy and cancer patients. CONCLUSIONS: Together, these observations indicate that plasma can harbour a low yet detectable level of cfmDNA. The results highlight the importance of accounting for contamination and provide an analytical decontamination framework to allow the accurate detection of cfmDNA for future biomarker studies in cancer and other diseases.
- Publisher
- BMC
- Keywords
- 16S rRNA gene; Cancer; Cell-free microbial DNA; Contamination; Microbiome
- Research Division(s)
- Bioinformatics
- PubMed ID
- 34162397
- Publisher's Version
- https://doi.org/10.1186/s13059-021-02401-3
- Open Access at Publisher's Site
https://doi.org/10.1186/s13059-021-02401-3- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2021-06-30 12:00:58
Last Modified: 2021-07-20 03:04:35